About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
Not Voodoo

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
Realizations in Biostatistics
ChemSpider Blog
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Eye on FDA
Chemical Forums
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa

Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
Gene Expression (I)
Gene Expression (II)
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net

Medical Blogs
DB's Medical Rants
Science-Based Medicine
Respectful Insolence
Diabetes Mine

Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem

Politics / Current Events
Virginia Postrel
Belmont Club
Mickey Kaus

Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« Nobel Season | Main | Nobel Chemistry Odds »

October 9, 2007

Blogroll Update

Email This Entry

Posted by Derek

For those of you who were taking the day off yesterday, there's a Nobel speculation post just below this one. Today, it's time for a long-overdue blogroll update. We have the In Vivo Blog to lead things off, and Away From the Bench, which I guess describes me right now, the fine line between Drugs and Poisons, industry news site Fierce Biotech, England's Peter Murray-Rust, the all-fluorous all the time F- Blog, a reluctant chemist doing Closeted Chemistry, Making Graphite Work (something I've never been able to do), the weirdly named Power of Goo, and the most aptly named Great Molecular Crapshoot.

Comments (5) + TrackBacks (0) | Category: Blog Housekeeping


1. coracle on October 9, 2007 11:35 AM writes...

Deeply honoured! Thanks for the link Derek.

Permalink to Comment

2. kayesdee on October 9, 2007 1:06 PM writes...

Derek, thanks for the link. Weirdly named -- I haven't heard that one before. But that's just how too many polymers are seen as from mostly non-polymer chemists: goo, soot, sticky stuff, oil, wax etc ;)

But of course there is real power and magic in these little critters… ;) even though in industry one doesn't really get to play with the hi-tech stuff so much. Long live the commodity and near-commodity markets.

Permalink to Comment

3. mevans on October 9, 2007 1:17 PM writes...

Thanks for the shoutout DL!

Permalink to Comment

4. Great Molecular Crapshoot on October 9, 2007 4:31 PM writes...

Many thanks for the inclusion in your blogroll and your specific mention of the Crapshoot in a post. I hope your move to Cambridge has worked out well.

Permalink to Comment

5. Chris on October 10, 2007 11:26 PM writes...

Thank you for adding my little blog to your blogroll!

Permalink to Comment


Remember Me?


Email this entry to:

Your email address:

Message (optional):

The Last Post
The GSK Layoffs Continue, By Proxy
The Move is Nigh
Another Alzheimer's IPO
Cutbacks at C&E News
Sanofi Pays to Get Back Into Oncology
An Irresponsible Statement About Curing Cancer
Oliver Sacks on Turning Back to Chemistry